These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2086813

  • 1. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A, Takaku F, Mizoguchi H, Nomura T, Aoki N, Yamaguchi H, Mutoh Y, Miura Y, Toyama K, Hirashima K.
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [Abstract] [Full Text] [Related]

  • 2. [Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
    Shimazaki C, Inaba T, Murakami S, Oku N, Itoh K, Ura Y, Nakagawa M, Fujita N.
    Jpn J Antibiot; 1990 Aug; 43(8):1402-6. PubMed ID: 2283708
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T, Akatsuka J, Hoshi Y, Uchiyama H, Fujisawa K, Kobayashi N, Ishidoya N, Ohira M, Takayama J, Ishida Y.
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infection.
    Takemoto Y, Kanamaru A, Nagai K, Masaoka T, Kitani T, Horiuchi A, Yonezawa T, Yasunaga K, Kageyama T, Tatsumi N.
    Jpn J Antibiot; 1990 Jan; 43(1):63-9. PubMed ID: 2190015
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
    Tsuda S, Tanaka S, Nakagawa H, Nishigaki H, Okuda T, Horiike S, Taniwaki M, Misawa S, Inazawa J, Abe T.
    Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
    [Abstract] [Full Text] [Related]

  • 6. Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
    Toyama K, Yaguchi M, Mizoguchi H, Masuda M, Urabe A, Ikeda Y, Aoki I, Shinbo T, Togawa A, Hirashima K, Miura Y, Hirose S, Tsuruoka N, Omine M, Kamakura M, Saito T, Arimori S, Aoki N, Kuraishi Y, Hirai H, Asano S, Mori M, Shirai T, Muto Y, Takaku F.
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1242-53. PubMed ID: 9011117
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H, Yamao H, Saito H, Ohno R, Hotta T, Ohnishi K, Murate T, Kagami Y, Mitomo Y, Nitta M.
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [Abstract] [Full Text] [Related]

  • 8. [Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology].
    Chimura T, Satou S, Funayama T, Oono T, Sakai Y, Morisaki N, Kanasugi H, Takahashi H, Saitou N, Miyata R.
    Jpn J Antibiot; 1991 Mar; 44(3):337-44. PubMed ID: 1880915
    [Abstract] [Full Text] [Related]

  • 9. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932
    [Abstract] [Full Text] [Related]

  • 10. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K.
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the second report). Study on effectiveness and safety in combination therapy using aztreonam and ampicillin. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R, Hashira S, Tajima T, Meguro H, Abe T, Sakata H, Kakehashi H, Fujita K, Murono K, Kaeriyama M.
    Jpn J Antibiot; 1990 Mar; 43(3):563-78. PubMed ID: 2197469
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
    Hirayama F, Masaoka T, Shibata H, Nagai K, Kitani T, Horiuchi A, Kawagoe H, Yasunaga K, Okamoto Y, Yonezawa T.
    Jpn J Antibiot; 1985 Sep; 38(9):2402-12. PubMed ID: 4079014
    [Abstract] [Full Text] [Related]

  • 13. [A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
    Sakata Y, Sawada Y, Kuroe K, Nakaji S, Takami H, Tsushima K, Saito S, Ogasawara H, Shinagawa H, Soma N.
    Jpn J Antibiot; 1992 Aug; 45(8):1009-15. PubMed ID: 1433889
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants].
    Motohiro T, Oda K, Aramaki M, Kawakami A, Tanaka K, Koga T, Shimada Y, Tomita S, Sakata Y, Tominaga K.
    Jpn J Antibiot; 1990 Mar; 43(3):503-23. PubMed ID: 2374300
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T, Tanaka K, Hasuike T, Hirai M, Misu K, Ota K, Ohira H, Nakao Y, Yasui Y, Inoue T.
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R, Hashira S, Tajima T, Meguro H, Abe T, Sakata H, Kakehashi H, Fujita K, Murono K, Kaeriyama M.
    Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K, Torii Y, Aoki I, Kikuchi M, Wakasugi K.
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [Abstract] [Full Text] [Related]

  • 19. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y.
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [Abstract] [Full Text] [Related]

  • 20. [Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
    Sawada H, Sasada M, Tajima M, Yamamoto K, Yasuda N, Omori S, Yumoto Y, Ishibashi T, Okada H, Suzuki T.
    Jpn J Antibiot; 1995 Feb; 48(2):271-7. PubMed ID: 7538179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.